Bretylium is an antiarrhythmic drug used in the treatment of ventricular arrhythmia. Its elimination rate constant in patients with renal insufficiency is 0.5 day-1, and its volume of distribution is 6 L/kg. How long it will take to reach steady state if a patient with renal insufficiency was started on a constant rate iv infusion of 90 mg/hr ?